本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Crescent Biopharma Inc

16.77
-0.4100-2.39%
盤後16.770.00000.00%16:10 EDT
成交量:66.59萬
成交額:1,127.63萬
市值:6.23億
市盈率:-2.26
高:18.57
開:17.60
低:16.32
收:17.18
52周最高:27.41
52周最低:8.72
股本:3,714.39萬
流通股本:1,595.35萬
量比:2.04
換手率:4.17%
股息:- -
股息率:- -
每股收益(TTM):-7.4105
每股收益(LYR):-12.8150
淨資產收益率:-160.75%
總資產收益率:-69.15%
市淨率:8.59
市盈率(LYR):-1.31

資料載入中...

2021/05/05

重要事件披露

8-K - Current report
2021/04/29

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/21

重要事件披露

8-K - Current report
2021/03/04

重要事件披露

8-K - Current report
2021/03/04

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/03

重要事件披露

8-K - Current report
2021/02/19

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/27

重要事件披露

8-K - Current report
2021/01/26

重要事件披露

8-K - Current report
2021/01/26

重要事件披露

8-K - Current report
2020/12/14

重要事件披露

8-K - Current report